Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal

NCT00003466 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00003466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1998
Completion date
July 31, 2005
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors